Stay updated with breaking news from Telmar Network Technology. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
/PRNewswire/ -- Odgers Berndtson, the world's sixth largest global executive search firm, is pleased to announce Craig Brechner has joined the firm as a...
Press release content from PR Newswire. The AP news staff was not involved in its creation.
/PRNewswire/ -- Odgers Berndtson, the world's sixth largest global executive search firm, is pleased to announce Craig Brechner has joined the firm as a...
Highlander Post Views: 1,658 UCRâs School of Medicine is partnering with Emalex Biosciences in producing a biological treatment for stuttering and will lead the second phase of clinical trials. UCR will serve as the lead site for a Phase 2 clinical trial that will evaluate the effectiveness of ecopipam, an investigational drug being tested for the treatment of stuttering in adults and Tourette syndrome in pediatric patients. Emalex Biosciences who developed ecopipam, will conduct the clinical trial. Ecopipam currently treats talk and speech therapy. However, if the trials cont...